ClinicalTrials.gov
ClinicalTrials.gov Menu

Low Carbohydrate Diet - Effect on Plasma Lipids and Metabolic Markers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01476436
Recruitment Status : Unknown
Verified April 2012 by Kjetil Retterstøl, Oslo University Hospital.
Recruitment status was:  Recruiting
First Posted : November 22, 2011
Last Update Posted : April 11, 2012
Sponsor:
Collaborator:
University of Oslo
Information provided by (Responsible Party):
Kjetil Retterstøl, Oslo University Hospital

Brief Summary:
Low carbohydrate diet may influence the plasma lipid levels.

Condition or disease Intervention/treatment Phase
Overweight and Obesity Type IIb Hyperlipidaemia Hypercholesterolemia Aggravated Other: Low carbohydrate dietary advice Other: Continue usual diet Not Applicable

Detailed Description:
Fasting plasma lipids will be measured in healthy volunteer randomized to low carbohydrate diet or usual diet for a period

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 22 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Low Carbohydrate Diet - Effect on Plasma Lipids and Metabolic Markers
Study Start Date : November 2011
Estimated Primary Completion Date : November 2013
Estimated Study Completion Date : November 2013

Arm Intervention/treatment
Experimental: Low carbohydrate dietary advice
Advice of a diet low in carbohydrate
Other: Low carbohydrate dietary advice
Dietary advice
Other Name: Dietary advice

Other: Continue usual diet
Blood and urine samples every 3 weeks. Participants continue to eat usual diet with no change in level of physical activity
Other Name: Lifestyle counseling to continue usual diet

Active Comparator: Lifestyle counseling to continue usual diet
Subjects shall continue to eat their usual daily diet with no low carbohydrate intervention
Other: Continue usual diet
Blood and urine samples every 3 weeks. Participants continue to eat usual diet with no change in level of physical activity
Other Name: Lifestyle counseling to continue usual diet




Primary Outcome Measures :
  1. Percent change in mean LDL-cholesterol after intervention with low carbohydrate diet [ Time Frame: From baseline to study end ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy volunteers

Exclusion criteria:

Any disease or use of prescriptional medication


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01476436


Contacts
Contact: Kjetil Retterstøl, MD PhD +47 22851521 kjetil.retterstol@medisin.uio.no
Contact: Kirsten Holven, PhD +47-22851361 kirsten.holven@medisin.uio.no

Locations
Norway
Oslo University Hospital Recruiting
Oslo, Norway, 0424
Contact: Kjetil Retterstøl, MD, PhD    +47 22851521    kjetil.retterstol@medisin.uio.no   
Contact: Kirsten Holven, PhD    +47-22851361    kirsten.holven@medisin.uio.no   
Principal Investigator: Kjetil Retterstøl, MD PhD         
Oslo University Hospital Not yet recruiting
Oslo, Norway
Contact: Kjetil Retterstøl, MD, PhD    +47 22851521    kjetil.retterstol@medisin.uio.no   
Principal Investigator: Kjetil Retterstøl, MD PhD         
Sponsors and Collaborators
Oslo University Hospital
University of Oslo
Investigators
Principal Investigator: Kjetil Retterstøl, MD PhD University of Oslo, Faculty of Medicine, Institute of Basic Medical Sciences, Department of Nutrition

Additional Information:
Responsible Party: Kjetil Retterstøl, Associate professor, MD PhD, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01476436     History of Changes
Other Study ID Numbers: REK195276
First Posted: November 22, 2011    Key Record Dates
Last Update Posted: April 11, 2012
Last Verified: April 2012

Keywords provided by Kjetil Retterstøl, Oslo University Hospital:
Cardio vascular risk factors

Additional relevant MeSH terms:
Overweight
Hypercholesterolemia
Hyperlipidemias
Hyperlipoproteinemias
Hyperlipidemia, Familial Combined
Body Weight
Signs and Symptoms
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Lipid Metabolism, Inborn Errors
Metabolism, Inborn Errors
Genetic Diseases, Inborn